Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Dotmatics supports Umicore Corporate R&D in processing of experimental data

    May 17, 2022, 15:46 PM by
    Full story
  • N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform

    May 17, 2022, 15:46 PM by
    Full story
  • Gainwell Appoints Karen Shields as Chief Client Engagement Officer

    May 17, 2022, 15:46 PM by
    Full story
  • VIDA Introduces New AI-Enabled Biomarker Services

    May 17, 2022, 15:46 PM by
    New VIDA analysis packages & novel biomarkers empower trial sponsors to unlock breakthrough insights
    Full story
  • BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

    May 17, 2022, 15:46 PM by
    Full story
  • BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

    May 17, 2022, 15:46 PM by
    BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.
    Full story
  • Source the Best PseudoUridines at Industry-Renowned Exhibitions

    May 17, 2022, 15:46 PM by
    BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022. With only a few days away, BOC Sciences sincerely invites all researchers concerned to pay a visit to its booths and have a constructive conversation with its knowledgeable experts.
    Full story
  • Scale-Up Facilities and Leading Expertise Drive Commercial Fermentation Progress

    May 17, 2022, 15:46 PM by
    BOC Sciences provides high-quality antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other fermented products as well as comprehensive CDMO services.
    Full story
  • ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Technology

    May 17, 2022, 15:46 PM by
    ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment As a part of the LifeSphere® platform, this solution will be named LifeSphere Clarity and will unlock crucial data patterns leveraging machine learning Rapid, robust benefit-risk assessment is key for all organizations collecting and processing large safety data sets Intelligent tool will drive industry-wide advancement of pharmacovigilance and patient safety capabilities
    Full story
  • Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions

    May 17, 2022, 15:46 PM by
    The American College of Cardiology (ACC) is leveraging Biofourmis’ AI-based predictive analytics platform and virtual health navigators for ACC’s TRANSFORM(3) study. The study—which focuses on underserved populations with a history of healthcare disparities—will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing specific chronic cardiovascular conditions.
    Full story
  • SeekGene Increases Efficiency by 500% by Leveraging MemVerge Memory Machine in the Cloud

    May 17, 2022, 15:46 PM by
    SeekGene, a biotechnology research firm focusing on single-cell technology, has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge Memory Machine running on AliCloud i4p compute instances. As a result, SeekGene is able to cut analytical time and costs significantly while optimizing their single-cell sequencing capabilities for researchers worldwide to promote faster development of precision medicine.
    Full story
  • Absolute Antibody to be featured on “World’s Greatest!...” television series

    May 17, 2022, 15:46 PM by
    Full story
  • NEWS RELEASE: Emmes launches Advantage eClinical

    May 17, 2022, 15:46 PM by
    Please find below the latest news story from Emmes (CRO) announcing the launch of its Advanatge eClinical as a standalone cloud native clinical technology platform – after more than two years in development. Unusually, the new platform will be available to both Emmes and non-Emmes customers and aims to increase access to a suitable platform particularly for smaller biotechs. Should you have any questions or would like to run a Q&A around this news, please do let me know.
    Full story
  • Biolog Announces New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products

    May 17, 2022, 15:46 PM by
    Biolog has appointed a new leadership team and secured a major investment to help drive widespread adoption of its industry-leading microbial identification and phenotypic profiling products
    Full story
  • Domainex appoints Dr Scott Martin as Analytical and Bioanalytical Group Leader

    May 17, 2022, 15:46 PM by
    Domainex Ltd, a leading integrated medicines research services partner, is pleased to announce that Dr Scott Martin has been appointed Analytical and Bioanalytical Group Leader with immediate effect.
    Full story
  • Global CRO to Showcase Respiratory Expertise at 2022 ATS International Conference

    May 17, 2022, 15:46 PM by
    Rho, a global full-service contract research organization (CRO), will showcase its expertise in pulmonary and respiratory related illnesses with attendees during the 2022 American Thoracic Society (ATS) International Conference, taking place at the Moscone Center in San Francisco, May 13-18. Rho experts will be at booth #2203 to share their knowledge of the latest advances in the rapidly evolving field of pulmonary medicine, some of which include asthma, COPD and cystic fibrosis. They will be available for one-on-one interviews during the conference with those interested in learning more about Rho’s industry developments.
    Full story
  • Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

    May 17, 2022, 15:46 PM by
    Full story
  • Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

    May 17, 2022, 15:46 PM by
    Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation’s leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon’s machine learning neuroanalytics platform.
    Full story
  • physIQ Announces Two New Appointments to Executive Leadership Team to Advance Digital Health Market Commercialization

    May 17, 2022, 15:46 PM by
    A leader in digital medicine, physIQ today announced the appointment of two new members to its executive leadership team to accelerate the organization’s commercialization strategy and growth trajectory. John Wilson has been named Senior Vice President and General Manager of Life Sciences, and Chris Englerth joins the team as Vice President of Marketing.
    Full story
  • Thermo Fisher Scientific Introduces QualTrak Biopharma qPCR Solutions to Streamline Biologics Development and Compliance

    May 17, 2022, 15:46 PM by
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136 (current)
  • 137
  • 138
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy